Details
Description
Inclusion Criteria
Exclusion Criteria
Details
Title A Phase I/II Study of Ruxolitnib with Front-Line Neoadjuvant and Post-Surgical Therapy in Patients with Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
IRB NRG-GY007
CC 16-877
Hospital Fairview, Main Campus
Stage Stage 3, Stage 4
Phase Phase 1, Phase 2
Disease Fallopian Tube, Gynecologic, Ovarian, Peritoneal
Drug Ruxolitinib
